FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2997612239> ?p ?o ?g. }

• W2997612239 endingPage "1358" @default.
• W2997612239 startingPage "1351" @default.
• W2997612239 abstract "Objectives: Ring finger protein 187 (RNF187) was recently demonstrated to be up-regulation and function as a promoter in multiple cancers. However, the roles of RNF187 in osteosarcoma (OS) are unclear. Here, we tried to reveal the clinicopathological and biological roles of RNF187 in OS. Materials and Methods: We employed the quantitative real-time polymerase chain reaction (qRT-PCR) and immunohistochemistry (IHC) to determine the expression of RNF187 in OS tissues and cells. Migration and invasion capacities were analyzed by wound healing and transwell assays, and colony formation and CCK8 assays were performed to investigate proliferative ability. The functional effects of RNF187 on OS drugs resistance were further determined by CCK8 and western blot assays. Then, the relationship between RNF187 expression and clinical implications was analyzed by tissue microarrays (TMAs) including 51 OS cases. Moreover, the prognostic value was also determined by Kaplan-Meier analysis. Results: We reported that RNF187 mRNA was significantly increased in OS tissues compared to matched nontumorous tissues (3.83 ±0.79 vs. 1.70 ± 0.63), which was in line with the IHC assay in TMAs. By RNA interference and cDNA transfection, we showed high level of RNF187 increased the migration, invasion and proliferation of OS cells. Moreover, we demonstrated that elevated RNF187 expression induced OS cell drugs resistance, activated the ERK1/2 molecular and markedly enhanced the BCL-2 expression. Clinically, OS patients with high level of RNF187 was associated with Histologic differentiation (p=0.001), an advanced Enneking stage (p=0.001), response to chemotherapy (p=0.004), and metastasis (p= 0.001). Clinically, our data displayed that the RNF187 overexpression in OS samples associated with shorten overall survival (p=0.001) and high tumor recurrence (p=0.001) in postoperative OS patients. Conclusions: Our results indicate that Elevated RNF187 expression is a new adverse outcomes marker for OS patients and may be used as a new therapeutic target of OS." @default.
• W2997612239 created "2020-01-10" @default.
• W2997612239 creator A5001673459 @default.
• W2997612239 creator A5014465282 @default.
• W2997612239 creator A5019286475 @default.
• W2997612239 creator A5024140491 @default.
• W2997612239 creator A5050230301 @default.
• W2997612239 creator A5052713807 @default.
• W2997612239 creator A5054579907 @default.
• W2997612239 creator A5060467128 @default.
• W2997612239 creator A5076768386 @default.
• W2997612239 creator A5091443775 @default.
• W2997612239 date "2020-01-01" @default.
• W2997612239 modified "2023-10-10" @default.
• W2997612239 title "High level of RNF187 contributes to the progression and drug resistance of osteosarcoma" @default.
• W2997612239 cites W1580800547 @default.
• W2997612239 cites W1964915114 @default.
• W2997612239 cites W1968792210 @default.
• W2997612239 cites W1975714506 @default.
• W2997612239 cites W1979156156 @default.
• W2997612239 cites W1979250970 @default.
• W2997612239 cites W2031633962 @default.
• W2997612239 cites W2036012693 @default.
• W2997612239 cites W2042619042 @default.
• W2997612239 cites W2058430410 @default.
• W2997612239 cites W2059184946 @default.
• W2997612239 cites W2061568155 @default.
• W2997612239 cites W2062436998 @default.
• W2997612239 cites W2081120309 @default.
• W2997612239 cites W2086351434 @default.
• W2997612239 cites W2101548895 @default.
• W2997612239 cites W2274419988 @default.
• W2997612239 cites W2408145068 @default.
• W2997612239 cites W2755866416 @default.
• W2997612239 cites W2765287744 @default.
• W2997612239 cites W2775382512 @default.
• W2997612239 cites W2789813374 @default.
• W2997612239 cites W2792896484 @default.
• W2997612239 cites W2897293614 @default.
• W2997612239 cites W2909794188 @default.
• W2997612239 cites W3191998012 @default.
• W2997612239 cites W4248865982 @default.
• W2997612239 doi "https://doi.org/10.7150/jca.33488" @default.
• W2997612239 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6995399" @default.
• W2997612239 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32047542" @default.
• W2997612239 hasPublicationYear "2020" @default.
• W2997612239 type Work @default.
• W2997612239 sameAs 2997612239 @default.
• W2997612239 citedByCount "4" @default.
• W2997612239 countsByYear W29976122392021 @default.
• W2997612239 countsByYear W29976122392022 @default.
• W2997612239 countsByYear W29976122392023 @default.
• W2997612239 crossrefType "journal-article" @default.
• W2997612239 hasAuthorship W2997612239A5001673459 @default.
• W2997612239 hasAuthorship W2997612239A5014465282 @default.
• W2997612239 hasAuthorship W2997612239A5019286475 @default.
• W2997612239 hasAuthorship W2997612239A5024140491 @default.
• W2997612239 hasAuthorship W2997612239A5050230301 @default.
• W2997612239 hasAuthorship W2997612239A5052713807 @default.
• W2997612239 hasAuthorship W2997612239A5054579907 @default.
• W2997612239 hasAuthorship W2997612239A5060467128 @default.
• W2997612239 hasAuthorship W2997612239A5076768386 @default.
• W2997612239 hasAuthorship W2997612239A5091443775 @default.
• W2997612239 hasBestOaLocation W29976122391 @default.
• W2997612239 hasConcept C104317684 @default.
• W2997612239 hasConcept C114851261 @default.
• W2997612239 hasConcept C11957725 @default.
• W2997612239 hasConcept C127561419 @default.
• W2997612239 hasConcept C142724271 @default.
• W2997612239 hasConcept C153911025 @default.
• W2997612239 hasConcept C193270364 @default.
• W2997612239 hasConcept C204232928 @default.
• W2997612239 hasConcept C2776415932 @default.
• W2997612239 hasConcept C2777760704 @default.
• W2997612239 hasConcept C48023723 @default.
• W2997612239 hasConcept C502942594 @default.
• W2997612239 hasConcept C54009773 @default.
• W2997612239 hasConcept C54355233 @default.
• W2997612239 hasConcept C55493867 @default.
• W2997612239 hasConcept C62112901 @default.
• W2997612239 hasConcept C71924100 @default.
• W2997612239 hasConcept C81885089 @default.
• W2997612239 hasConcept C86803240 @default.
• W2997612239 hasConcept C89423630 @default.
• W2997612239 hasConceptScore W2997612239C104317684 @default.
• W2997612239 hasConceptScore W2997612239C114851261 @default.
• W2997612239 hasConceptScore W2997612239C11957725 @default.
• W2997612239 hasConceptScore W2997612239C127561419 @default.
• W2997612239 hasConceptScore W2997612239C142724271 @default.
• W2997612239 hasConceptScore W2997612239C153911025 @default.
• W2997612239 hasConceptScore W2997612239C193270364 @default.
• W2997612239 hasConceptScore W2997612239C204232928 @default.
• W2997612239 hasConceptScore W2997612239C2776415932 @default.
• W2997612239 hasConceptScore W2997612239C2777760704 @default.
• W2997612239 hasConceptScore W2997612239C48023723 @default.
• W2997612239 hasConceptScore W2997612239C502942594 @default.
• W2997612239 hasConceptScore W2997612239C54009773 @default.
• W2997612239 hasConceptScore W2997612239C54355233 @default.

• next